WallStreetZenWallStreetZen

NASDAQ: GRI
Gri Bio Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Gri Bio earnings were -$13.2M for the trailing 12 months ending Sep 30, 2025, with -99.4% growth year over year. The latest GRI earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$3.4M, up 16.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, GRI reported annual earnings of -$10.1M, with -22.4% growth.

GRI past earnings growth

How has GRI's earnings growth performed historically?

Company
-99.41%
Industry
60.09%
Market
54.42%
GRI's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
GRI's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

GRI earnings history

Current Revenue
$0.0
Current Earnings
-$13.2M
Current Profit Margin
0%

GRI Return on Equity

Current Company
-498.7%
Current Industry
-21.3%
Current Market
35.2%
GRI's Return on Equity (-498.7%)... subscribe to Premium to read more.
High Return on Equity Performance

GRI undefined

Current Company
-260%
Current Industry
-8.8%
GRI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when GRI announces earnings.

GRI undefined

Current Company
-556.15%
Current Industry
-3.4%
GRI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GRI vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
GRI-$11.25M-$13.16M-99.41%$14.40
MLEC-$5.72M-$8.28MN/A-$2.10
ATON-$6.74M-$6.78MN/A-$5.72
NCEL-$7.05M-$9.34MN/A-$8.20
SPRC$4.22M$3.73MN/A-$2.79
View Top Biotech Stocks

Gri Bio Earnings Reports & History FAQ

What were Gri Bio's earnings last quarter?

Gri Bio (NASDAQ: GRI) reported Q3 2025 earnings per share (EPS) of -$1.28, up 88.79% year over year. Total GRI earnings for the quarter were -$3.36 million. In the same quarter last year, Gri Bio's earnings per share (EPS) was -$11.42.

If you're new to stock investing, here's how to buy Gri Bio stock.

Is Gri Bio profitable or losing money?

As of the last Gri Bio earnings report, Gri Bio is currently losing money. Gri Bio's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$11.25 million, a 36.07% increase year over year.

What was GRI's earnings growth in the past year?

As of Gri Bio's earnings date in Q4 2025, Gri Bio's earnings has grown -99.41% year over year. This is 159.5 percentage points lower than the US Biotechnology industry earnings growth rate of 60.09%. GRI earnings in the past year totalled -$13.16 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.